肾肿瘤穿刺活检的系统综述与荟萃分析:准确性、安全性及对临床决策的影响
该系统综述与荟萃分析纳入103项研究,评估肾肿瘤穿刺活检(RTB)的诊断准确性、安全性及临床影响。RTB pooled诊断率为90%,对恶性肿瘤的汇总敏感性和特异性分别为99%和85%;良恶性一致性和组织学亚型一致性高(96%和89%),但分级一致性中等。总体并发症率低(3%),Clavien-Dindo≥3并发症可忽略(<1%),出血事件1%,肿瘤种植 pooled比例为0%。RTB改变39%患者的临床管理,避免28%患者的积极治疗。
要点
- RTB诊断率高(90%),对恶性肿瘤敏感性99%、特异性85%。
- 良恶性及组织学亚型一致性高,但肿瘤分级可靠性仅中等。
- 并发症率低(3%),严重并发症<1%,肿瘤种植风险极低。
核心结论
- RTB安全且诊断率高,对恶性肿瘤敏感性极好,良恶性和组织学亚型一致性高,但肿瘤分级可靠性仅中等。
- RTB是细化肾肿块诊断和支持个体化决策的重要辅助工具。
研究设计与样本
- 系统综述与荟萃分析,系统检索MEDLINE、Embase和Cochrane CENTRAL,纳入103项研究。
- 诊断性能采用分层双变量随机效应模型合成;活检与手术标本一致性采用随机效应荟萃分析估计 pooled proportions。
- 偏倚风险采用QUADAS-2评估。
主要发现
- RTB pooled诊断率为90%。
- 对恶性肿瘤的汇总敏感性和特异性分别为99%和85%。
- RTB与手术病理一致性:良恶性96%,组织学亚型89%,分级四层64%、两层78%。
- 总体并发症率3%,Clavien-Dindo≥3并发症<1%,出血事件1%(仅2例需栓塞)。
- 肿瘤种植仅1项研究报告,pooled种植比例为0%。
临床怎么用
- RTB可用于肾肿块患者的诊断细化,支持个体化决策。
- RTB对良恶性鉴别和组织学亚型判断可靠性高,但分级解释需谨慎。
局限性
- 多数研究存在高偏倚风险,主要因患者选择和时间流程。
- 研究以回顾性为主。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: We performed a systematic review and meta-analysis to evaluate the diagnostic accuracy, safety, and clinical impact of renal tumor biopsy (RTB) in managing renal cell carcinoma. METHODS: MEDLINE, Embase, and Cochrane CENTRAL were systematically searched for studies evaluating diagnostic accuracy, complications, and clinical impact of RTB. Diagnostic performance was synthesized using hierarchical bivariate random-effects models; concordance between biopsy and surgical specimens was assessed using pooled proportions that were estimated using random-effects meta-analysis. Risk of bias was evaluated with QUADAS-2. KEY FINDINGS AND LIMITATIONS: Overall, 103 studies were included. The pooled diagnostic yield of RTB was 90%. Summary sensitivity and specificity for malignancy were 99% and 85%, respectively. Concordance between RTB and surgical pathology was high for benign versus malignant (96%) and histological subtype (89%), but moderate for grade (four-tier: 64%; two-tier: 78%). The overall complication rate was low (3%), with negligible (<1%) Clavien-Dindo ≥3 complications and 1% bleeding events (with only two patients requiring embolization). Tumor seeding was reported only in one study with a pooled seeding proportion of 0%. RTB findings was associated with a change in clinical management in 39% of patients and avoidance of active treatment in 28%. Most studies were at high risk of bias, mainly due to patient selection and flow/timing, and were predominantly retrospective. CONCLUSIONS AND CLINICAL IMPLICATIONS: RTB is safe and high-yield, with excellent sensitivity, high concordance for benign vs malignant and histotype, but only moderate reliability for tumor grade. RTB is therefore an important aid in refining diagnosis in patients with a renal mass and supporting individualized decision-making.
引用
- Mjaess G, Nicolazzini M, Amparore D, et al. Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making. Eur Urol. 2026. PMID: 42498608. doi:10.1016/j.eururo.2026.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。